Preoperative levels of CEA, CA19-9, and CA125 were analyzed on 768 patients with GC and found above the cut-off levels in only 15.4, 8.7, and 5.7% of all cases, respectively (4). This evidence concerns the gene CEACAM5 and gastric cancer.